ARCHIVES

NeoRx Suspends Accrual, Treatment In Phase III trial Using STR For Myeloma.

This article is from The Cancer Letter archive.

Vol. 26 No. 44 | December 1, 2000

Download PDF Visit The Full Archive

Related Articles

DCPC Board Defers Two Concepts More Approvals Listed

October 19, 1984

“Do What’s Right for People With Cancer”. Glick’s Credo

May 24, 1996

Also: NCCN Committee Reaffirms Clinical Guideline Covering Avastin for Breast Cancer Indication

July 22, 2011

Oblimersen Combination Improves CLL Survival

December 28, 2007

2013 Appropriations: Additional Level of Grant Review Proposed As NIH Prepares For Cost Cutting

March 30, 2012

ACS: Decline in Death Rates Saved Over 1.3 Million Lives

January 10, 2014